Literature DB >> 10755672

Psychosocial approaches to dual diagnosis.

R E Drake1, K T Mueser.   

Abstract

Recent research elucidates many aspects of the problem of co-occurring substance use disorder (SUD) in patients with severe mental illness, which is often termed dual diagnosis. This paper provides a brief overview of current research on the epidemiology, adverse consequences, and phenomenology of dual diagnosis, followed by a more extensive review of current approaches to services, assessment, and treatment. Accumulating evidence shows that comorbid SUD is quite common among individuals with severe mental illness and that these individuals suffer serious adverse consequences of SUD. The research further suggests that traditional, separate services for individuals with dual disorders are ineffective, and that integrated treatment programs, which combine mental health and substance abuse interventions, offer more promise. In addition to a comprehensive integration of services, successful programs include assessment, assertive case management, motivational interventions for patients who do not recognize the need for substance abuse treatment, behavioral interventions for those who are trying to attain or maintain abstinence, family interventions, housing, rehabilitation, and psychopharmacology. Further research is needed on the organization and financing of dual-diagnosis services and on specific components of the integrated treatment model, such as group treatments, family interventions, and housing approaches.

Entities:  

Mesh:

Year:  2000        PMID: 10755672     DOI: 10.1093/oxfordjournals.schbul.a033429

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  46 in total

Review 1.  Managing comorbid schizophrenia and substance abuse.

Authors:  R E Drake; K T Mueser
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 2.  Psychosocial treatments for schizophrenia.

Authors:  A S Bellack; S A Brown
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

3.  Further validation of the Psycho-Social Well-Being Scale (PSWS) with community clients.

Authors:  Thomas O'Hare; Margaret V Sherrer; Hilary Smith Connery; Jay Thornton; Annamaria LaButti; Kelly Emrick
Journal:  Community Ment Health J       Date:  2003-04

4.  Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems.

Authors:  Alisa B Busch; Arnold M Epstein; Thomas G McGuire; Sharon-Lise T Normand; Richard G Frank
Journal:  J Ment Health Policy Econ       Date:  2015-09

5.  Training in Substance-Related and Addictive Disorders, Part 1: Overview of Clinical Practice and General Recommendations.

Authors:  Gilles Fleury; Robert Milin; David Crockford; Leslie Buckley; Dara Charney; Tony P George; Nady el-Guebaly
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

6.  Treatment services and service delivery models for dually diagnosed clients: variations across mental health and substance abuse providers.

Authors:  Virginia Gil-Rivas; Christine E Grella
Journal:  Community Ment Health J       Date:  2005-06

Review 7.  [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Authors:  T Wobrock; R D'Amelio; P Falkai
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

8.  Using information technology to evaluate the detection of co-occurring substance use disorders amongst patients in a state mental health system: implications for co-occurring disorder state initiatives.

Authors:  Frederick Y Huang; Douglas M Ziedonis; Hsou Mei Hu; Anna Kline
Journal:  Community Ment Health J       Date:  2007-08-10

9.  [State-dependent motivational interviewing for people with schizophrenia and substance use: results of a randomised controlled trial].

Authors:  A Bechdolf; B Pohlmann; J Güttgemanns; C Geyer; K Lindner; C Ferber; E Gouzoulis-Mayfrank
Journal:  Nervenarzt       Date:  2012-07       Impact factor: 1.214

10.  [Substance use associated disorders: frequency in patients with schizophrenic and affective psychoses].

Authors:  L Hermle; R Szlak-Rubin; K L Täschner; P Peukert; A Batra
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.